Senior Vice President, Quality @ (September 2021 - July 2024)
Senior Vice President, Regulatory Affairs and Quality @ (May 2018 - September 2021)
Vice President, Regulatory Affairs and Pharmacovigilance @ PaxVax, Inc. (December 2014 - April 2018)
Vice President, Regulatory Affairs and Quality @ PaxVax, Inc. (March 2014 - December 2014)
Director, Global Regulatory Affairs @ (January 2009 - March 2014)
Director (Head), Business Development @ OncoGenex Pharmaceuticals (July 2006 - July 2008)
Director (Head), Regulatory Affairs @ OncoGenex Pharmaceuticals (December 2003 - July 2006)
Manager, Regulatory Affairs @ (September 2000 - December 2003)
Manager, Regulatory Affairs and Quality @ (September 1999 - September 2000)
Manager, Quality (Validation) @ Novopharm (January 1997 - September 1999)
QC Chemist @ Novopharm (September 1990 - December 1996)
Kevin Smyth Education
Simon Fraser University
Master's degree (Toxicology)
1998-1998
University of Calgary
Bachelor's of Science (Biochemistry)
1990
Kevin Smyth Skills
Microsoft Office
HPLC
Project Management
Business Development
Change Management
Public Speaking
Clinical Trials
Medical Writing
Regulatory Affairs
Drug Development
Pharmaceutical Industry
Clinical Development
Biotechnology
GLP
Validation
Toxicology
Life Sciences
IND
Regulatory Requirements
FDA
Biologics
Project Planning
Commercialization
Vaccines
Kevin Smyth Summary
Kevin Smyth, based in Kirkland, WA, US, is currently a Executive Vice President, Quality at Iovance Biotherapeutics, Inc.. Kevin Smyth brings experience from previous roles at Iovance Biotherapeutics, Inc. and PaxVax, Inc.. Kevin Smyth holds a 1998 - 1998 Master's degree in Toxicology @ Simon Fraser University. With a robust skill set that includes Microsoft Office, HPLC, Project Management, Business Development, Change Management and more. Kevin Smyth has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kevin Smyth?
Find contact details for 700 million professionals.